StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Medivation (MDVN) PT Raised to $63 at Credit Suisse on M&A Valuation
May 3, 2016 7:27 AM
Credit Suisse analyst Kenneth MacKay raised his price target on Medivation (NASDAQ: MDVN) to $63.00 (from ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst PT Change
Mergers and Acquisitions
Rumors
Next Articles
Medivation (MDVN) PT Raised to $52 at Jefferies
May 2, 2016 7:47 AM
Stifel Raises Medivation Inc (MDVN) PT to $66 with Company In Play
May 2, 2016 7:19 AM
UPDATE: AstraZeneca (AZN), Novartis (NVS),Pfizer (PFE) Said Among Firms Weighing Bids for Medivation (MDVN)
April 29, 2016 12:29 PM
Medivation board rejects Sanofi's $9.3 billion takeover offer
April 29, 2016 9:19 AM
Sanofi (SNY) Issues Commentary on Medivation's (MDVN) Rejection of Takeover Proposal; Remains Committed to Combination
April 29, 2016 9:06 AM
Sanofi Comments on Medivation's Rejection of Proposal
April 29, 2016 9:05 AM
Medivation (MDVN) Rejects Sanofi's (SNY) Unsolicited Proposal
April 29, 2016 8:46 AM
Medivation's Board of Directors Unanimously Rejects Sanofi's Unsolicited Proposal
April 29, 2016 8:45 AM
Sanofi, Medivation dig in for big biotech takeover battle
April 29, 2016 4:11 AM
